Factorial has rolled out a striking out-of-home activation in Paris, transforming the promise of AI-powered efficiency into a tangible, real-world experience. Conceptualised by creative agency ...

The two companies agreed to cooperate in the development of all-solid-state battery materials. In sample testing of materials from multiple suppliers, POSCO Future M demonstrated good rate capability.

AI drug discovery specialist Recursion Pharmaceuticals is shelving three of its most advanced drug prospects in an effort to cut costs following a merger last year. Alongside its latest quarterly ...

I'm diving deep into the intersection of infrastructure and machine learning. I'm fascinated by exploring scalable architectures, MLOps, and the latest advancements in AI-driven systems ...

In a significant leap for electric vehicle technology, Mercedes-Benz has embarked on road tests of an EQS sedan outfitted with a pioneering lithium-metal solid-state battery. This initiative, launched ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion. The ...

A partnership between Massachusetts-based Factorial and storied car brand Mercedes-Benz to bring an all-solid-state battery to market with amazing performance is making progress, according to Electrek ...

Abstract: Total least squares (TLS) has been comprehensively explored over the last few decades due to its excellent statistical properties. However, the unsatisfactory efficiency of TLS from the ...

Recursion has stumbled through an early test of its tech-enabled approach to drug discovery, reporting a hit on its phase 2 primary endpoint of safety and tolerability but failing to wow on the ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.